June 11, 2020 Letters were mailed to our hematology or medical oncology patients in early June with new details about the transition of medical oncology services to our partner hospitals, Ascension Borgess and Bronson, in 2021. We want to help patients plan ahead for changes coming to medical oncology services they receive from us. Bronson [...]
West Michigan Cancer Center & Institute for Blood Disorders (WMCC) this week received 105 cases of hand sanitizer, produced and donated by Perrigo Company plc, to protect patients and frontline healthcare workers during the COVID-19 healthcare crisis. Perrigo is a manufacturer of over-the-counter pharmaceuticals whose North American operation is based in Allegan. “We are extremely grateful [...]
West Michigan Cancer Center & Institute for Blood Disorders (WMCC) has received re-certification by the QOPI® Certification Program LLC, a subsidiary of the American Society of Clinical Oncology, Inc. (ASCO®). The QOPI® Certification Program builds on ASCO’s Quality Oncology Practice Initiative (QOPI®), providing a three-year certification for outpatient hematology-oncology practices that meet nationally recognized standards [...]
Two physicians have joined the radiation oncology team at West Michigan Cancer Center & Institute for Blood Disorders (WMCC), a collaboration of Ascension Borgess and Bronson Healthcare Group. Daniel Chamberlain, MD, is WMCC’s new division chief of radiation oncology. Dr. Chamberlain has 14 years’ experience in clinical and academic medicine, most recently as a faculty member [...]
West Michigan Cancer Center & Institute for Blood Disorders (WMCC), a collaboration of Ascension Borgess and Bronson Healthcare Group, has named Bridget VandenBussche to lead the organization as Interim Executive Director. VandenBussche takes the helm of WMCC after two and a half years as director of quality improvement and risk. She has been with the [...]
KALAMAZOO, MICHIGAN —Care for women with breast cancer has made tremendous strides over the past decade and that includes guidance on how to move forward with life after treatment. One of the most beneficial tools provided to breast cancer patients at the West Michigan Cancer Center & Institute for Blood Disorders (WMCC) is a survivorship [...]
West Michigan Cancer Center & Institute for Blood Disorders (WMCC), a collaboration of Borgess / Ascension and Bronson Healthcare Group, is pleased to announce the addition of three providers. Casey Hay, MD is a gynecologic oncologist with 7 years’ experience in clinical medicine. Dr. Hay earned her medical degree [...]
FOR IMMEDIATE RELEASE CONTACT: Lynne Emons Phone: 269-384-8624 Email: Lemons@wmcc.org West Michigan Cancer Center & Institute for Blood Disorders in Kalamazoo, Michigan has been granted a three-year/full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. Accreditation by the NAPBC is only given to [...]
WMCC radiation therapy staff is ready to begin treatments using the newly installed TrueBeam linear accelerator. Back row, left to right: Mazen Mislmani, MD; Jeff Tkac; Jeffrey Radawski, MD; Chen Chen; Kris Lutz. Front row, left to right: Linda Grossheim, MD; Renu Sharma; Lori Burleigh; Holly Henderson; Sherri Jipping. KALAMAZOO, MICHIGAN —West Michigan [...]
KALAMAZOO, Mich.–West Michigan Cancer Center & Institute for Blood Disorders (WMCC) and Sturgis Hospital have formed a clinical partnership that will expand patients’ access to advanced cancer care, innovative clinical trials and survivorship resources in St. Joseph County. “We’re very pleased to collaborate with the West Michigan Cancer Center,” said Rob LaBarge, Sturgis Hospital President [...]
